Definitive Contract HHSN261201200077C

This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute, a civilian agency, to Buffalo Biolabs, LLC, a small business, for the development of anticancer agents under the Small Business Innovation Research (SBIR) program. The award amount is $1,496,764.00 and the period of performance is until October 31, 2014. The contract is a Phase II SBIR action, which indicates it is for the continued development and testing of a promising technology that was previously funded under a...

This is a federal contract award from the Department of Health and Human Services (HHS) to Buffalo Biolabs, LLC, a small business located in Buffalo, NY. The contract is for a Small Business Innovation Research (SBIR) Program Phase I research project in the biomedical field, with a total contract value of $148,725.00 and a completion date of March 31, 2010. The contract is a Firm Fixed Price Definitive Contract, which indicates the scope of work and deliverables were pre-determined. As a SBIR...

<p>This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the U.S. Department of Health and Human Services (HHS) to Buffalo Biolabs, LLC, a small business located in Buffalo, New York. The contract is for basic physical sciences research with a firm fixed price of $149,987 and a period of performance ending on March 31, 2010. The contract was awarded on September 30, 2009 and has a total small business set-aside designation.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&amp;D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&amp;D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...

<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>

<p>This is a $150,000 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Bioptix Diagnostics, Inc., a for-profit manufacturer. The contract is for Phase I of a Small Business Innovation Research (SBIR) project under Topic 281. The contract has a completion date of June 29, 2011. As an SBIR award, this contract was set aside for small businesses.</p>

<p>This is a federal contract awarded by the National Cancer Institute, a civilian agency, to Transgenex Nanobiotech Inc., a minority-owned small business. The contract, valued at $224,999.00, is for a Small Business Innovation Research (SBIR) Program Phase I action. The contract is a definitive, firm-fixed-price contract with a completion date of September 15, 2015. This contract is set aside for small businesses.</p>

This is a federal contract award from the National Cancer Institute, a civilian agency, to Zoneone Pharma Inc., a small business contractor. The contract is for &quot;OTHER FUNCTIONS - R &amp; D BIOMEDICAL (BASIC RESEARCH)&quot; with a ceiling value of $215,999.00. It is a definitive, firm fixed-price contract with a completion date of July 10, 2013. The place of performance is San Francisco, CA. As a small business set-aside award, this contract supports the National Cancer Institute's research...

<p>This is a definitive, firm fixed-price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Benevir Biopharm, Inc., a small business, for R&amp;D medical/biomedical services. The contract has a ceiling value of $199,904.00 and a completion date of February 12, 2014. The contract was set aside for small businesses.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract, valued at $185,116, is a firm-fixed-price definitive contract for research and development work. The contract was awarded on September 24, 2010 and has an ultimate completion date of June 23, 2011. As an SBIR Phase I contract, it is focused on the early-stage feasibility study of a...